Navigation Links
Over 70 Percent of Physicians Say There Is a High Need for More Diabetes Drugs with Novel Mechanisms of Action While 15 Percent Say the Same for DPP-IV Inhibitors
Date:12/17/2009

WALTHAM, Mass., Dec. 17 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that over 70 percent of surveyed U.S. physicians indicate there is a high need for diabetes drugs with novel mechanisms of action versus 15 percent who say there is a high need for additional DPP-IV inhibitors. Both surveyed physicians and patients favor agents with excellent glucose lowering ability and physicians in particular say the most influential attribute would be if an agent could reduce HbA1c levels by two percent.

"Physicians we surveyed also tell us that they prefer an agent with an excellent safety profile, which is not surprising given the cardiovascular safety concerns associated with GlaxoSmithKline's Avandia and the more recent pancreatitis association with both Amylin/Eli Lilly's Byetta and Merck's Januvia," stated Nicole Westphal, Ph.D., analyst and product manager at Decision Resources. "For surveyed type 2 diabetes patients, an emerging therapy with disease modifying potential (one that improves the function of insulin producing cells) is also highly desirable."

The new report entitled Brand Perceptions in Noninsulin Antidiabetics also identifies segments of physicians and type 2 diabetes patients that each uses a different mix of criteria to make treatment decisions. The physician segment comprised of young, urban, weight-conscious specialists favor Byetta and will likely drive adoption of new GLP-1 analogues such as, Novo Nordisk/Scios's Victoza and Alkermes/Amylin/Eli Lilly's Byetta LAR. Given this segment's reliance on clinical evidence to drive decisions, this physician segment is an ideal target for companies developing novel drugs.

"The majority of surveyed physicians predict that out of these two agents, Byetta LAR will have the most significant impact on type 2 diabe
'/>"/>

SOURCE Decision Resources
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Patent Expiries of Blockbuster Antibiotics Will Fuel a Decline of More Than 15 Percent in the Community-Acquired Pneumonia Drug Market
2. $232 Billion Personalized Medicine Market to Grow 11 Percent Annually, says PricewaterhouseCoopers
3. Russias Hepatitis C Virus Drug Market Will Grow Nine Percent Annually, Reaching $327 Million by 2013
4. Sales of HER2-Targeting Agents for Breast Cancer, Including Herceptin and Tykerb/Tyverb, Will Grow by 3.3 Percent Annually from 2008 to 2018
5. Thoratec Reports 14 Percent Growth in Cardiovascular Division Sales as Third Quarter Revenues Increase Nine Percent
6. Ninety Eight Percent of Surveyed Rheumatologists Will Prescribe Roches Actemra for Rheumatoid Arthritis
7. Burton Medicals New Diagnostic Examination Light, the AIM LED Provides 10 Percent More Illumination and 10 Times Greater Lamp Life
8. Accurays Treatment Planning Service Active at 20 Percent of U.S. CyberKnife Centers
9. Dartmouth Medical School Faculty Member and Anesthesiologist Invents Revolutionary Catheter System Designed to Increase Rate of Successful IV Insertions by 75 Percent
10. Second-Generation Female Condom is Now Available in the United States; FC2 Female Condom Will Cost 30 Percent Less than Predecessor
11. Abbott Cuts Use of Oil and Coal by 35 Percent
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... TAIPEI , Sept. 1, 2015 ... 2,500 employees, SHL Group has rapidly reached 3,000 ... yet rapid growth in the injectable drug delivery ... A global leader in the design ... SHL offers innovative designs, robust manufacturing capabilities, a ...
(Date:9/1/2015)... Sept. 1, 2015 Pressure BioSciences, Inc. ... in the development and sale of broadly enabling, ... the worldwide life sciences industry, today announced the ... the Company,s PCT Platform could play a significant ... This role is based on PCT,s unique ability ...
(Date:9/1/2015)...  Abbott (NYSE: ABT ) announced today positive one-year ... comparing the safety and effectiveness of Abbott,s fully dissolving ... market-leading, permanent drug eluting stent. The trial was conducted ... and enrolled 400 people with coronary artery disease, the ... be featured at a late-breaking session today at ESC ...
Breaking Medicine Technology:SHL Group Reaches Major Milestone of 3000 Employees 2New Scientific Publication Suggests Pressure BioSciences' PCT Platform Could Play Significant Role in Personalized/Precision Medicine 2New Scientific Publication Suggests Pressure BioSciences' PCT Platform Could Play Significant Role in Personalized/Precision Medicine 3New Scientific Publication Suggests Pressure BioSciences' PCT Platform Could Play Significant Role in Personalized/Precision Medicine 4New Scientific Publication Suggests Pressure BioSciences' PCT Platform Could Play Significant Role in Personalized/Precision Medicine 5Abbott Announces Positive Results of Its Naturally Dissolving Stent from ABSORB Japan Study 2Abbott Announces Positive Results of Its Naturally Dissolving Stent from ABSORB Japan Study 3Abbott Announces Positive Results of Its Naturally Dissolving Stent from ABSORB Japan Study 4
... , NEW YORK, November 17 ... biomarkers will help identify and monitor patients at risk,of developing ... are,cared for in prenatal clinics around the world. , ... highly-respected National,Institute of Child and Human Development of the National ...
... , NEW YORK, Nov. 17 ... Street is the first laser hair removal center in New ... system by Cynosure, Inc., a leading developer and manufacturer of ... Elite MPX, which incorporates Cynosure,s patented MultiPlex sequencing technology, is ...
Cached Medicine Technology:New Study Heralds Use of Blood Biomarkers to Predict Preeclampsia 2New Study Heralds Use of Blood Biomarkers to Predict Preeclampsia 3Romeo and Juliette Laser Hair Removal Is First Center in New York City to Own Cynosure's New Elite MPX(TM) Laser System 2
(Date:9/1/2015)... ... September 01, 2015 , ... ... pleased to announce their partnership with Apex Physical Therapy (Apex) is ... continue to provide kind, compassionate, and empathetic care to local residents from their ...
(Date:9/1/2015)... San Diego, CA (PRWEB) , ... September 01, 2015 , ... ... with Bellus Academy will present “The Beauty Behind the Fashion” on Thursday, Oct. ... San Diego® (FWSD), will shine the spotlight on the collaboration between fashion and professional ...
(Date:9/1/2015)... ... 01, 2015 , ... Horizon Blue Cross Blue Shield of New Jersey (BCBSNJ) ... the LATINA Style 50 Report that recognizes companies that provide the best career opportunities ... BCBSNJ climbs from number 24 to 21 of the 50 Best Companies for Latinas. ...
(Date:9/1/2015)... Rolling Meadows, Ill. (PRWEB) , ... September 01, ... ... medical procedures done by members of the American Society for Dermatologic Surgery, according ... case. , The 2015 ASDS Consumer Survey on Cosmetic Dermatologic Procedures – which ...
(Date:9/1/2015)... London, UK (PRWEB) , ... September 01, 2015 ... ... of a vacuum that creates negative pressure inside a wound to remove exudates, ... market for treatment devices (comprising portable devices, stand-alone devices, disposable devices, and canisters, ...
Breaking Medicine News(10 mins):Health News:ProRehab Physical Therapy Partnership with Apex Physical Therapy Now Official 2Health News:ProRehab Physical Therapy Partnership with Apex Physical Therapy Now Official 3Health News:Celebrity Hairstylist Ted Gibson Explores Fusion of Fashion and Beauty at “Beauty Behind the Fashion” at Fashion Week San Diego Proceeds to benefit THIRST Project 2Health News:Celebrity Hairstylist Ted Gibson Explores Fusion of Fashion and Beauty at “Beauty Behind the Fashion” at Fashion Week San Diego Proceeds to benefit THIRST Project 3Health News:Horizon Blue Cross Blue Shield of New Jersey Named One of the 50 Best Companies for Latinas by Latina Style Magazine 2Health News:Horizon Blue Cross Blue Shield of New Jersey Named One of the 50 Best Companies for Latinas by Latina Style Magazine 3Health News:Survey: Consumers Prefer ASDS Members 2Health News:Survey: Consumers Prefer ASDS Members 3Health News:World Negative Pressure Wound Therapy Market Assessed by GlobalData in In-demand Report Published at MarketPublishers.com 2Health News:World Negative Pressure Wound Therapy Market Assessed by GlobalData in In-demand Report Published at MarketPublishers.com 3
... N.J., July 23 VS Holdings, Inc. (the "Company"), the parent of ... statement on Form S-1 with the U.S. Securities and Exchange Commission relating ... consummation of the offering, the Company will be renamed Vitamin Shoppe, Inc. ... are expected to be offered by the Company. , ...
... , Diverse Donors Make the Difference , ... Awareness Day is August 1, and New York Blood Center (NYBC) and its ... on the community to help us meet the great need for blood from ... Minority Donor Awareness Day emphasized minority organ and tissue donation, but blood donation ...
... , , Partnership to ... , ARLINGTON, Va., July 23 Health ... Clinton Climate Initiative (CCI), a project of the William J. Clinton ... their environmental impact, particularly in the area of carbon reduction. ...
... colitis, but oily fish could be protective, study shows, , ... a common polyunsaturated fatty acid could be a contributing factor ... colitis, researchers say. , In a new study, participants ... than double the chance of developing the painful inflammation and ...
... by researchers at the Ohio State University Comprehensive Cancer ... prostate tumors gain the ability to grow without need ... an advanced and currently incurable stage of prostate cancer. ... of the journal Cell , focuses on androgen ...
... new studies reveal a way to increase the body,s appetite for ... (AML), a form of cancer with a particularly poor survival rate. ... cells that sends a "don,t eat me" signal to the macrophage ... to the reports in the July 24th issue of the journal ...
Cached Medicine News:Health News:Vitamin Shoppe Files Registration Statement for Initial Public Offering of Common Stock 2Health News:Vitamin Shoppe Files Registration Statement for Initial Public Offering of Common Stock 3Health News:The Gift of Life Flows Through Your Veins! 2Health News:The Gift of Life Flows Through Your Veins! 3Health News:Health Care Without Harm Partners With Clinton Climate Initiative to Help Hospitals and Healthcare Facilities Reduce Environmental Impact 2Health News:Health Care Without Harm Partners With Clinton Climate Initiative to Help Hospitals and Healthcare Facilities Reduce Environmental Impact 3Health News:Fatty Acids in Diet Linked to Bowel Disease Risk 2Health News:Scientists discover key event in prostate cancer progression 2Health News:Stripping leukemia-initiating cells of their 'invisibility cloak' 2
RIA kit for the quantitative determination of autoantibodies to thyroid peroxidase (TPO) in serum....
For the quantitative determination of Estradiol (E2) concentration in human serum or plasma....
... Estradiol (E2) concentration in human serum or plasma. ... a phenolic A ring. This steroid hormone ... is the most potent natural Estrogen, produced mainly ... by the adrenal cortex, and the male testes. ...
... (cTnI) has been useful in the differential ... (ED) with chest pain. 18-20 ... levels of sensitive and specific biomarkers, such ... creatine kinase (CK-MB), and myoglobin, are increased ...
Medicine Products: